Eruptive cutaneous squamous cell carcinoma and psoriasis: response to cetuximab.

Cutaneous squamous cell carcinomas (CSCCs) comprise 20-30% of nonmelanoma skin cancers (NMSCs), and continue to increase in incidence. We report a case of a patient with severe psoriasis who had recurrent and eruptive CSCCs on her leg, which were successfully treated with cetuximab and radiotherapy. The patient had successful long-term clearance of her skin tumours, with the additional finding of resolution of psoriasis while on cetuximab therapy.

Screening options for Down syndrome: how women choose in real clinical setting.

OBJECTIVE: To study pregnant women's preference among various screening options for Down syndrome (DS) in routine clinical setting, and its potential association with women's demographic characteristics. METHODS: Women aged 35 years and older carrying singleton pregnancy were offered a variety of screening tests for DS before 14 weeks of gestation. Their preference was confirmed by the test they actually underwent. The association between women's choice of test and a number of demographic characteristics was studied using multinomial regression. RESULTS: Among 1967 eligible women, 619 opted for first-trimester screening test (FTS), 924 for partial integrated test (PIT), and 424 for full integrated test (FIT). Nulliparous women and working mothers were more likely to choose FTS and FIT. Women with history of subfertility were more likely to choose FIT. Women with family history of chromosomal abnormalities were more likely to choose FTS. The choice of screening test could be predicted for 49.9% of women using four demographic characteristics. CONCLUSIONS: Among older women of predominantly Chinese ethnicity, integrated test is a favorite alternative to FTS. Their choice of DS screening test can be predicted by their obstetric and socioeconomic characteristics. Many women show willingness to pay for a test with a lower false-positive rate.

Effect of fetal diagnosis on the outcomes of second-trimester pregnancy termination for fetal abnormalities: a pilot study.

OBJECTIVE: To explore whether the outcomes of second-trimester pregnancy termination for fetal abnormalities are affected by fetal diagnoses. METHODS: This was a retrospective review of cases undergoing second-trimester pregnancy termination for the fetal diagnoses of hemoglobin Barts, trisomy 21, and trisomy 18 during the period from 1999 to 2006. The affected pregnancies were terminated by vaginal misoprostol. The outcome measures were: (1) abortion within 24 hours after misoprostol commencement, (2) histology-confirmed incomplete abortion, and (3) experience of significant side effects during termination (temperature over 39 degrees C or need for metoclopramide for vomiting). RESULTS: One hundred and twenty cases were available for analysis. After adjusting for maternal age, parity, history of cesarean delivery, body mass index, gestation, and fetal hydrops, pregnancy termination for trisomy 21 was associated with a higher risk of incomplete abortion than trisomy 18 and hemoglobin Barts (odds ratio 5.25, 95% confidence interval 1.24-22.19, p = 0.024). The chance of abortion within 24 hours and experience of significant side effects were not found to be associated with fetal diagnosis. CONCLUSIONS: Pregnancy termination for trisomy 21 is associated with a higher risk of incomplete abortion. Fetal diagnosis affects the outcome of pregnancy termination.

The effect of gestational age on the outcome of second-trimester termination of pregnancies for foetal abnormalities.

OBJECTIVE: To explore the effect of gestational age on the outcome of second-trimester termination of pregnancies for foetal abnormalities. METHOD: A retrospective study was conducted on 280 pregnancies terminated for foetal abnormalities in the second trimester using vaginal misoprostol. The gestational age at termination was divided into three groups: 13-16 weeks, 17-20 weeks and 21-23 weeks. The likelihood of (1) abortion within 24 h of commencement of misoprostol, (2) incomplete abortion and (3) experiencing significant side effects was compared among these three gestational groups after adjusting for maternal age, parity and body mass index (BMI). RESULTS: Compared to termination after 20 weeks, pregnancy termination for foetal abnormality before 17 weeks of gestation was associated with higher chance of incomplete abortion (OR 2.2, 95% CI 1.07-4.61, p = 0.032) and lower chance of experiencing significant side effects (OR 0.11, 95% CI 0.01-0.91, p = 0.041). CONCLUSION: Women undergoing pregnancy termination for foetal abnormalities in the early second trimester should be informed of possible higher chance of incomplete abortion.

E1A transformed normal human prostate epithelial cells contain a 16q deletion.

The difficulty of maintaining long-term prostate cell cultures has hindered the development of essential models for understanding prostate cancer. We report here the establishment of two 12S E1A transformed non-tumorigenic prostate epithelial cell strains, and their characterization. The two clonal cell strains, TP2 and TP4, proliferated for approximately 40 passages before senescence. Both exhibited a strong dependence on exogenous peptide growth factors and an immunophenotype characteristic of their prostate epithelial origin. Cytogenetic analysis revealed a consistent deletion on the q arm of chromosome 16 in TP2 with an otherwise normal karyotype. Band-specific microdissection generated region-specific probes from 16q23, which when used in fluorescence in situ hybridization (FISH) revealed that the region was deleted in 83% of metaphases analyzed. By cytogenetic analysis and FISH, the q arm of 16 was found deleted from the genome of TP4 in 60% of cells analyzed. Lost sequences on 16q-16q23 in particular--in prostate cancer have been observed by a variety of methods. Localization of common region of deletion has been determined from these studies to be distal to 16q23. Our findings suggest that 16q23 may be of major importance in the development of prostate cancer, and may harbor tumor suppressor elements.

Relationship between newborn and maternal iron status and haematological indices.

The haemoglobin, mean corpuscular volume, mean corpuscular haemoglobin, haematocrit, serum iron and total iron binding capacity, and serum ferritin concentrations in umbilical cord blood samples taken from 96 appropriate-for-gestational age infants delivered at term were measured and compared to the respective maternal values measured at 36 weeks' gestation. All the values were higher in cord blood. Only maternal mean corpuscular volume and mean corpuscular haemoglobin were correlated with cord serum iron. Cord blood haematological indices were not correlated with either gestation at delivery or birth weight. However, newborn serum ferritin was positively correlated with gestation at delivery, while the maternal:newborn ferritin ratio was inversely correlated with gestation and birth weight. The results suggest that maternal haematological and iron indices are not predictive of the haemoglobin or iron status of the newborn, and that the fetus continues to take up iron from the mother until delivery.

Second-trimester thyroid function and pregnancy outcome in mothers with hyperthyroidism. Birth weight related to mid-trimester triiodothyronine and RBC zinc.

Thyroid function at 24-28 weeks gestation was compared between 26 mothers with hyperthyroidism (16 on antithyroid treatment and 10 in remission without treatment) and 15 normal pregnant controls. There was no difference in the total and free thyroxine (TT4 and FT4) or in the total and free triiodothyronine (TT3 and FT3) concentrations, but the erythrocyte zinc (RBC Zn) concentration was significantly lower in the study group (187.3 +/- 46.6 mumol/l RBC versus 223.6 +/- 3.7 mumol/l RBC, p less than 0.01). In the study group, both birth weight and gestation at delivery were significantly correlated with TT3 (r = -0.500, p less than 0.02 and r = -0.460, p less than 0.05, respectively) as well as with RBC Zn (r = 0.473, p less than 0.02 and r = 0.573, p less than 0.01, respectively). The results suggest that plasma concentration of TT3 and of RBC Zn at 24-28 weeks gestation may be helpful prognostic factors in the management of pregnant patients with hyperthyroidism.

The role of transcutaneous electrical nerve stimulation in management of labour in obstetric patients.

The study evaluated the effect of transcutaneous electrical nerve stimulation (TENS) in the management of labour. It comprised of 125 subjects with 93 primiparae and 32 multiparae. They were divided into 3 groups. The first group received electrical stimulation from the TENS unit (TENS); the second group (placebo group) had the TENS machine connected but with no current from the TENS unit (TPL); whereas the third group had no machine application (control group). Analgesic requirements, pain assessment, labour duration, Obstetric outcome, and the comments from mother and midwife were analysed. No negative effects on the mothers and babies were reported. Neither was there any objective clinical significant differences demonstrated among the 3 groups.

Pregnancy outcome in women with labor-onset hypertension. Similar outcome between labor-onset hypertension and preeclampsia.

Labor-onset hypertension is a poorly documented category, and there is scanty information concerning the outcome of pregnancy in this condition. A retrospective study was performed to compare the pregnancy outcome of 36 patients with labor-onset hypertension (group A) with 36 patients with classical preeclampsia diagnosed before labor (group B) who were matched for parity and age. There was no difference in age, past history of hypertensive pregnancies or family history of hypertension between the two groups. The need for intrapartum hypertensive and anticonvulsant treatment as well as the outcome of pregnancy were similar in both groups. The only significant difference was that group A patients had lower maximum and booking systolic and diastolic pressures. The results indicate that labor-onset hypertension represents a late manifestation of the preeclampsia process, because these patients had lower blood pressure in pregnancy and would not be identified until intrapartum elevation of blood pressure satisfied the diagnostic criteria of preeclampsia.

Plasma and erythrocyte zinc and birth weight in pre-eclamptic pregnancies.

Plasma and erythrocyte zinc concentrations in 45 proteinuric pre-eclamptic Chinese women were measured. There was no difference in either the plasma or erythrocyte zinc concentration between pre-eclamptic patients with and without intrauterine growth retardation. There was no correlation between either plasma or erythrocyte zinc concentration with the gestation at delivery, birth weight, mean arterial pressure and plasma albumin concentration. On the other hand, both plasma albumin concentration and mean arterial pressure were significantly correlated to birth weight, and the mean arterial pressure was also significantly higher in patients with intrauterine growth retardation. Plasma and erythrocyte zinc are not useful as indices of severity in pre-eclampsia.

Maternal thyroid hormones and outcome of pre-eclamptic pregnancies.

Plasma concentrations of total and free thyroxine (TT4 and FT4), total and free triiodothyronine (TT3 and FT3), thyroid-stimulating hormone (TSH), plasma albumin and urate were measured in 39 proteinuric pre-eclamptic patients presenting before labour. Pre-eclamptic patients had significantly lower FT4 and higher TSH concentrations compared with values in third trimester normotensive pregnancies. There was a significantly higher frequency of lower TT4, TT3 and high TSH levels in the subgroup of pre-eclamptic patients who had low-birthweight babies. Thyroid hormone concentrations were not correlated with gestation at delivery or birthweight but, with the exception of FT4, were correlated with plasma albumin and urate concentrations. Plasma TSH correlated with birthweight and with plasma urate. The results suggest that mild biochemical hypothyroidism may be found in proteinuric pre-eclampsia, and the concentrations of TT4, TT3, FT3 and TSH may reflect the severity of pre-eclampsia.

Zinc and birth weight in uncomplicated pregnancies.

The relationship between zinc status and birth weight in uncomplicated pregnancies was studied in 59 nulliparous and 27 multiparous Chinese women with singleton pregnancies, delivered at term. Maternal and umbilical cord blood, maternal pubic hair and a segment of the umbilical cord were collected at delivery for analysis. The zinc concentration was significantly higher (p less than 0.0001) in the plasma of newborn infants (13.9 +/- 2.8 mumol/l) than in maternal plasma (9.3 +/- 2.2 mumol/l), while the converse was found in tissue (60.8 +/- 17.0 vs 208.1 +/- 96.2 micrograms/g, p less than 0.0001). There was no significant correlation between birth weight and either maternal or newborn plasma or tissue zinc concentrations. Parity had no significant effect on maternal or newborn zinc concentrations in tissue and plasma.

A longitudinal study of changes in erythrocyte zinc concentration in hyperemesis gravidarum.

Erythrocyte zinc concentration and plasma thyroid hormones were measured in 32 patients admitted to hospital because of hyperemesis gravidarum. At presentation, 8 patients had elevated total and free thyroxine concentrations. The initial erythrocyte zinc concentration in these 8 patients was not different from the others, but in 5 of them, a transient drop in the erythrocyte zinc concentration was observed 2-12 weeks later, and which returned to normal towards the end of pregnancy. The lowest erythrocyte zinc concentration in the hyperthyroxinaemic group (171.0 +/- 31.7 mumol/l of RBC) was significantly lower than that of the normothyroxinaemic group (214.2 +/- 33.9 mumol/l of RBC) (p less than 0.01). This indicates that hyperthyroxinaemia in patients with hyperemesis gravidarum represents true hyperthyroidism, but is different from classical thyrotoxicosis in that the elevation of thyroid hormones is transient.

Antenatal complications and perinatal outcome in patients with nausea and vomiting-complicated pregnancy.

The incidence of nausea and vomiting-complicated pregnancy was determined in a district hospital in Hong Kong. Nausea was present in 11.4% and vomiting in 63.5% of pregnant women. Patients with vomiting complicating early pregnancy have a statistically significant higher incidence of antepartum haemorrhage of indeterminate origin. The incidences of medical diseases complicating pregnancy, other major antenatal complications, and the neonatal outcome were not different between vomiting and non-vomiting patients.